Anaphylactic and anaphylactoid reactions occurring during anesthesia in France in 1999-2000

Anesthesiology

Volumn 99, Issue 3, 2003, Pages 536-545

  Mertes, Paul Michel ^a   Laxenaire, Marie Claire ^a   Alla, François ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANESTHETIC AGENT; ANTIBIOTIC AGENT; ATRACURIUM; CEPHALOSPORIN; CISATRACURIUM; GALLAMINE; GELATIN; HETASTARCH; HISTAMINE; HYPNOTIC AGENT; IMMUNOGLOBULIN E; KETOPROFEN; LATEX; MIDAZOLAM; MIVACURIUM; NEUROMUSCULAR BLOCKING AGENT; OPIATE DERIVATIVE; PANCURONIUM; PENICILLIN DERIVATIVE; PROTAMINE; QUINOLONE DERIVATIVE; RIFAMYCIN; ROCURONIUM; SUXAMETHONIUM; THIOPENTAL; TRYPTASE; UNINDEXED DRUG; VANCOMYCIN; VECURONIUM;

ALLERGIC ASTHMA; ANAMNESIS; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; ATOPY; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR DISEASE; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; DRUG RESPONSE; FOOD ALLERGY; FRANCE; HEART ARREST; HUMAN; HYPOTENSION; PRIORITY JOURNAL; PROTEIN DETERMINATION; RADIOALLERGOSORBENT TEST; SHOCK; SKIN MANIFESTATION; SKIN TEST;

ADULT; AGED; ANAPHYLAXIS; ANESTHESIA; ANESTHETICS; CROSS REACTIONS; DRUG HYPERSENSITIVITY; FEMALE; FRANCE; HISTAMINE; HUMANS; IMMUNOGLOBULIN E; LATEX HYPERSENSITIVITY; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; RISK FACTORS; SERINE ENDOPEPTIDASES; SKIN TESTS; TRYPTASES;

EID: 0041629639     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200309000-00007     Document Type: Article

References (47)

1. Fisher MM, More DG: The epidemiology and clinical features of anaphylactic reactions in anaesthesia. Anaesth Intensive Care 1981; 9:226-34
2. Fisher MM, Baldo BA: The incidence and clinical features of anaphylactic reactions during anesthesia in Australia. Ann Fr Anesth Reanim 1993; 12:97-104
3. Laxenaire MC: Drugs and other agents involved in anaphylactic shock occurring during anaesthesia: A French multicenter epidemiological inquiry. Ann Fr Anesth Reanim 1993; 12:91-6
4. Laxenaire MC: Epidémiologie des réactions anaphylactoïdes peranesthésiques: Quatrième enquête multicentrique (juillet 1994-décembre 1996). Ann Fr Anesth Reanim 1999; 18:796-809
5. Watkins J: Second report from an anaesthetic reactions advisory service. Anaesthesia 1989; 44:157-9
6. Clarke RS, Watkins J: Drugs responsible for anaphylactoid reactions in anaesthesia in the United Kingdom. Ann Fr Anesth Reanim 1993; 12:105-8
7. Pepys J, Pepys EO, Baldo BA, Whitwam JG: Anaphylactic/anaphylactoid reactions to anaesthetic and associated agents: Skin prick tests in aetiological diagnosis. Anaesthesia 1994; 49:470-5
8. Galletly DC, Treuren BC: Anaphylactoid reactions during anaesthesia: Seven years' experience of intradermal testing. Anaesthesia 1985; 40:329-33
9. Moscicki RA, Sockin SM, Corsello BF, Ostro MG, Bloch KJ: Anaphylaxis during induction of general anesthesia: Subsequent evaluation and management. J Allergy Clin Immunol 1990; 86:325-32
10. Gram LE, Hallas J, Andersen M: Pharmacovigilance based on prescription databases. Pharmacol Toxicol 2000; 86:13-5
11. Reducing the risk of anaphylaxis during anaesthesia: Abbreviated text. Ann Fr Anesth Reanim 2002; 21(suppl 1):7s-23s
12. Gueant JL, Mata E, Monin B, Moneret-Vautrin DA, Kamel L, Nicolas JP, Laxenaire MC: Evaluation of a new reactive solid phase for radioimmunoassay of serum specific IgE against muscle relaxant drugs. Allergy 1991; 46:452-8
13. Guilloux L, Ricard-Blum S, Ville G, Motin J: A new radioimmunoassay using a commercially available solid support for the detection of IgE antibodies against muscle relaxants. J Allergy Clin Immunol 1992; 90:153-9
14. Clergue F, Auroy Y, Pequignot F, Jougla E, Lienhart A, Laxenaire MC: French survey of anesthesia in 1996. ANESTHESIOLOGY 1999; 91:1509-20
15. Laxenaire MC, Moneret-Vautrin DA, Widmer S, Mouton C, Gueant JL, Bonnet MC, Bricard H, Facon A, Lesage F, Valfrey J, F. Leynadier, J. Motin, G. Occelli: Anesthetics drugs responsible for anaphylactic shock: French multicenter study. Ann Fr Anesth Reanim 1990; 9:501-6
16. Laxenaire MC: Substances responsible for peranesthetic anaphylactic shock: A third French multicenter study (1992-94). Ann Fr Anesth Reanim 1996; 15:1211-8
17. Laxenaire M, Mertes PM, GERAP: Anaphylaxis during anaesthesia: Results of a 2 year survey in France. Br J Anaesth 2001; 21:549-58
18. Jooste E, Klafter F, Hirshman CA, Emala CW: A mechanism for rapacuronium-induced bronchospasm: M2 muscarinic receptor antagonism. ANESTHESIOLOGY 2003; 98:906-11
19. Laroche D, Bricard H, Laxenaire MC: Allergo-anesthesia consultation: Not enough patients are tested after an anaphylactoid anesthetic incident. Ann Fr Anesth Reanim 1998; 17:89-90
20. Whittington T, Fisher MM: Anaphylactic and anaphylactoid reactions. Clin Anaesthesiol B Clin Anaesthesiol 1998; 12:301-23
21. Watkins J: Adverse reaction to neuromuscular blockers: Frequency, investigation, and epidemiology. Acta Anaesthesiol Scand Suppl 1994; 102:6-10
22. Fisher MM, Baldo BA: Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth 1998; 80:26-9
23. Fisher M, Baldo BA: Anaphylaxis during anaesthesia: Current aspects of diagnosis and prevention. Eur J Anaesthesiol 1994; 11:263-84
24. Guttormsen AB: Allergic reactions during anaesthesia: Increased attention to the problem in Denmark and Norway. Acta Anaesthesiol Scand 2001; 45: 1189-90
25. Rose M, Fisher M: Rocuronium: High risk for anaphylaxis? Br J Anaesth 2001; 86:678-82
26. Watkins J: Incidence of UK reactions involving rocuronium may simply reflect market use. Br J Anaesth 2001; 87:522
27. Fisher MM, Bowey CJ: Intradermal compared with prick testing in the diagnosis of anaesthetic allergy. Br J Anaesth 1997; 79:59-63
28. Moneret-Vautrin DA, Laxenaire MC: Skin tests in diagnosis of allergy to muscle relaxants and other anaesthetic drugs, Allergic Reactions to Anaesthetics: Clinical and Basic Aspects. Edited by Assem ES. Basel, Karger, 1992, pp 145-55
29. Mertes PM, Laxenaire MC: Allergic reactions occurring during anaesthesia. Eur J Anaesthesiol 2002; 19:240-62
30. Levy JH, Gottge M, Szlam F, Zaffer R, McCall C: Weal and flare responses to intradermal rocuronium and cisatracurium in humans. Br J Anaesth 2000; 85:844-9
31. Beaudouin E, Prestat F, Schmitt M, Kanny G, Laxenaire MC, Moneret-Vautrin DA: High risk of sensitization to latex in children with spina bifida. Eur J Pediatr Surg 1994; 4:90-3
32. Arellano R, Bradley J, Sussman G: Prevalence of latex sensitization among hospital physicians occupationally exposed to latex gloves. ANESTHESIOLOGY 1992; 77:905-8
33. Holzman RS: Clinical management of latex-allergic children. Anesth Analg 1997; 85:529-33
34. Cremer R, Kleine-Diepenbruck U, Hoppe A, Bläker F: Latex allergy in spina bifida patients by primary prophylaxis. Allergy 1998; 53:709-11
35. Laxenaire MC, Charpentier C, Feldman L: Anaphylactoid reactions to colloid plasma substitutes: Incidence, risk factors, mechanisms: A French multicenter prospective study. Ann Fr Anesth Reanim 1994; 13:301-10
36. Fisher MM, Bowey CJ: Alleged allergy to local anaesthetics. Anaesth Intensive Care 1997; 25:611-4
37. Youngman PR, Taylor KM, Wilson JD: Anaphylactoid reactions to neuromuscular blocking agents: A commonly undiagnosed condition? Lancet 1983; 2: 597-9
38. Charpin D, Benzarti M, Hemon Y, Senft M, Alazia M, Arnaud A, Vervloet D, Charpin J: Atopy and anaphylactic reactions to suxamethonium. J Allergy Clin Immunol 1988; 82:356-60
39. Porri F, Lemiere C, Birnbaum J, Guilloux L, Lanteaume A, Didelot R, Charpin D, Vervloet D: Prevalence of muscle relaxant sensitivity in a general population: Implications for a preoperative screening. Clin Exp Allergy 1999; 29:72-5
40. Cohen DE, Scheman A, Stewart L, Taylor J, Pratt M, Trotter K, Prawer S, Warshaw E, Rietschel R, Watsky K, Schwarzenberger K, Zug K, Shama S, Godwin L, Kosann MK, Wilson BA: American Academy of Dermatology's position paper on latex allergy. J Am Acad Dermatol 1998; 39:98-106
41. Brehler R, Theissen U, Mohr C, Luger T, Kolling R, Webb M, Wastell C: "Latex-fruit syndrome": Frequency of cross-reacting IgE antibodies. Allergy 1997; 52:404-10
42. Ring J, Messmer K: Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1977; 1:466-9
43. Jacobsen J, Lindekaer AL, Ostergaard HT, Nielsen K, Ostergaard D, Laub M, Jensen PF, Johannessen N: Management of anaphylactic shock evaluated using a full-scale anaesthesia simulator. Acta Anaesthesiol Scand 2001; 45:315-9
44. Fisher M: Treatment of acute anaphylaxis. BMJ 1995; 311:731-3
45. Laroche D, Vergnaud MC, Sillard B, Soufarapis H, Bricard H: Biochemical markers of anaphylactoid reactions to drugs: Comparison of plasma histamine and tryptase. ANESTHESIOLOGY 1991; 75:945-9
46. Veien M, Szlam F, Holden J, Yamaguchi K, Denson D, Levy J: Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells. ANESTHESIOLOGY 2000; 92:1074-81
47. Laroche D, Lefrancois C, Gerard JL, Dubois F, Vergnaud MC, Gueant JL, Bricard H: Early diagnosis of anaphylactic reactions to neuromuscular blocking drugs. Br J Anaesth 1992; 69:611-4